logo

FDA Calendar

Share
Company Name Gilead Sciences Inc.
Drug Name KTE-X19 (BLA)
Event Name FDA decision on KTE-X19 for the treatment of adult patients with relapsed or refractory mantle cell lymphoma
Event Date 08/10/2020
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar